SAFE Pharma (Beijing Saifu)
Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.
3 contract research organizations in our directory list both Gene Therapy Studies and Dog among their capabilities, across 2 countries. 3 report GLP capability and 2 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 3 CROs. Order rotates daily so no lab is permanently listed first.
Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.
Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.